1-4 of 4
Atsuo Ozaki, MD
Close
Sort by
Journal Articles

A Pilot Study of Reduced-Intensity Conditioning Stem Cell Transplantation with T-Cell Replete HLA-Mismatched Allograft from Child to Parent Patient for the Treatment of Refractory Adult T-Cell Leukemia.

Hiroshi Fujiwara, MD, PhD, Atsuo Ozaki, MD, Makoto Yoshimitsu, MD, Heiichiro Hamada, MD, Hideaki Kawada, MD, Kakushi Matsushita, MD.Ph.D, Naomichi Arima, MD.Ph.D, Chuwa Tei, MD.Ph.D
Journal: Blood
Blood (2006) 108 (11): 5406.
https://doi.org/10.1182/blood.V108.11.5406.5406
Published: 2006
Journal Articles

Soluble CD30 Can Distinguish Disease Progression from Acute GVHD in Patients with Adult T Cell Leukemia/Lymphoma Who Received Allogeneic Hematopoietic Stem Cell Transplantation.

Makoto Yoshimitsu, MD, Hiroshi Fujiwara, MD, PhD, Noriko Aoki, MD, Atsuo Ozaki, MD, Heiichiro Hamada, MD, Kakushi Matsushita, MD, Naomichi Arima, MD, Chuwa Tei, MD
Journal: Blood
Blood (2006) 108 (11): 4423.
https://doi.org/10.1182/blood.V108.11.4423.4423
Published: 2006
Journal Articles

Graft vs. HTLV-I Virus Effect Can Be Induced Independently of Graft vs. Leukemia Effect in Patients with Adult T-Cell Leukemia Who Received Allogeneic Hematopoietic Stem Cell Transplantation.

Hiroshi Fujiwara, MD, PhD, Makoto Yoshimitsu, MD, Atsuo Ozaki, MD, Tomohiro Kozako, Ph.D, Naomichi Arima, MD.Ph.D, Chuwa Tei, MD.Ph.D
Journal: Blood
Blood (2006) 108 (11): 2903.
https://doi.org/10.1182/blood.V108.11.2903.2903
Published: 2006
Journal Articles

Anti-HTLV-I Tax-Protein-Specific CTL Is Not Necessarily Resposible for Graft-v.s.-ATL Effect in Allogeneic SCT for Patients with Adult T-Cell Leukemia/Lymphoma.

Hiroshi Fujiwara, MD, PhD, Izumi Masamoto, Tomohiro Kozako, PhD, Hideaki Kawada, MD, Makoto Yoshimitsu, MD, Noriko Aoki, MD, Atsuo Ozaki, MD, Heiichiro Hamada, MD, Kakushi Matsushita, MDPhD, Naomichi Arima, MD, PhD, Chuwa Tei, MDPh.D
Journal: Blood
Blood (2005) 106 (11): 5353.
https://doi.org/10.1182/blood.V106.11.5353.5353
Published: 2005